National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:10:20
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 21695-715-60 | EA - Each | 21695-715 | f869ce8b-ae8b-4f8e-ab7e-24c7bc771ecd | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 21695-715 | 21695-715-60 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076690-001 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | |
| A076690-002 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | |
| A076690-003 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 |
| A076690-004 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | |
| A076690-005 | VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076690-001 | AB |
| A076690-002 | AB |
| A076690-003 | AB |
| A076690-004 | AB |
| A076690-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-001 | VENLAFAXINE HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | AB | 2006-08-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-002 | VENLAFAXINE HYDROCHLORIDE | EQ 37.5MG BASE | TABLET / ORAL | AB | 2006-08-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-003 | VENLAFAXINE HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | AB | RS | 2006-08-03 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-004 | VENLAFAXINE HYDROCHLORIDE | EQ 75MG BASE | TABLET / ORAL | AB | 2006-08-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-005 | VENLAFAXINE HYDROCHLORIDE | EQ 100MG BASE | TABLET / ORAL | AB | 2006-08-03 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076690-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A076690-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A076690-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A076690-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A076690-005 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A076690-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076690-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076690-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076690-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076690-005 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076690-005 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076690-005 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076690-005 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076690-005 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076690-005 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076690-005 | AB | 1 | 03ed91905a0d… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.